is convening a meeting of PCAC to consider changing the classification of seven popular peptides, thus allowing them to be compounded and sold by prescription
Research findings are mixed, with some studies linking GLP-1 drugs to higher risks of mental health issues
Digital Access
doi: 10.1001/jama.2023.24945
Luana Stanescu 10 Bin Zhang 11 Alexander Miethke 1 Jonathan Dillman 1 Andrew Trout 1 , 1 Cincinnati Children's Hospital, 2 AdventHealth Medical Group, 3 Duke University Hospital, 4 NYU Langone Health, 5 Nemours Childrens Hospital, 6 Childrens Healthcare of Atlanta, 7 University of Texas Southwestern, 8 Childrens National Hospital, 9 Medical University of South Carolina, 10 Seattle Childrens Hospital, 11 Cincinnati Childrens Hospital Background: The aim of this study was to assess inter-radiologist agreement for Magnetic Resonance Cholangiopancreatography (MRCP) interpretation in pediatric patients with known or suspected cholangiopathy